8-KLeadership ChangesExhibits & Filings

AMGEN INC 8-K Report, Executive Changes (Oct 22, 2010)

Filed October 22, 2010For Securities:AMGN

Summary

This 8-K filing from Amgen Inc. (AMGN) on October 21, 2010, primarily reports on the transition of George J. Morrow, Executive Vice President, following his announced retirement. The company has entered into a one-year consulting services agreement with Mr. Morrow, effective February 1, 2011, extending his engagement beyond his retirement date. The agreement aims to leverage Mr. Morrow's expertise in critical areas such as R&D product pipeline commercialization and product launches. This arrangement provides Amgen with continued access to valuable institutional knowledge and strategic insight during a period of significant product development and market introduction. Investors can view this as a measure to ensure continuity and smooth transitions in key operational areas.

Key Highlights

  • 1Amgen Inc. has entered into a one-year consulting agreement with Executive Vice President George J. Morrow, effective February 1, 2011.
  • 2Mr. Morrow is retiring from his executive role effective January 31, 2011.
  • 3The consulting agreement aims to utilize Mr. Morrow's expertise in commercialization of the R&D product pipeline and product launches.
  • 4Compensation for the consulting services includes a quarterly fee of $100,000 for up to 80 hours of service per quarter, with additional hourly rates for extra hours.
  • 5The agreement allows for an optional extension for a second year.
  • 6Amgen will reimburse Mr. Morrow for reasonable travel-related expenses incurred during his consulting services, excluding travel to the Thousand Oaks facility.
  • 7The consulting agreement includes provisions for conflict of interest and allows for termination by either party with 30 days' notice.

Frequently Asked Questions